Page results
-
This page aims to support and supplement the information provided in the video titled Managing the Emotional Impact of Cancer, available on uclh.nhs.uk/wellbeing.
-
This clinic provides a service within North Central London to children and young people up to 18 years of age with unusual, complicated or recurrent infections. A family infection clinic is also provided where family groups may be reviewed together by both adult and paediatric teams.
-
The Upper GI service provides treatment for, amongst other conditions, oesophageal and gastric cancers as well as for benign conditions (acid reflux and motility disorders). There is close collaboration with the GI physiology and laser centre.
-
Our clinical neurophysiology department performs tests which record information from the brain or the nervous system. There are two main tests performed in our outpatient department, Electroencephalogram (EEG) and Nerve conduction studies (NCS).
-
This page offers advice for patients with an auditory processing difficulty/disorder (APD).
-
This page explains how to hand express your colostrum. It is for mothers/birthing parents who will have a baby on the neonatal unit.
-
At University College Hospital education is provided for inpatients of school age on the paediatric floor (T11) and the adolescent floor (T12).
-
Our non-emergency patient transport service is provided by G4S. G4S may use approved external sub-contractors to meet the demand of the service and/or the specific needs of our patients.
-
The cochlear implant programme was founded in 1982, and we were the first clinical cochlear implant programme in the UK. The team has been involved with the successful implantation of more than 2,000 patients, both adults and children, from all over the UK.
-
UCLH provides an audiological service for GPs who would like to refer patients for age related audiological assessments.
File results
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0327 - NHS long-term plan/ prevention strategy